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Non-Hodgkin's malignant lymphomas are malignant 
haemopathies characterized with clinical and 
anatomy diversity.1,2 Extra-ganglionic forms are less 
frequent and represent 1/3rd of the sites, which 36% 
are gastrointestinal locations. The most common is 
gastric lymphoma of MALT.3,4 Among the exposure 
factors, there are infectious agents including 
Helicobacter pylori in 80% of Gastric lymphoma5,6, 
the hepatitis C virus in 38.4% of low grade 
lymphomas.7 Diffuse Large B cell lymphoma (DLBCL) 
is aggressive lymphoma. It accounts for about 40% of 
all Non-Hodgkin Lymphomas. Localized forms are 
infrequent and represent 35 to 45% of cases, and 
disseminated forms 55 to 65% of cases.8 The primary 
localization of Diffuse Large B cell lymphoma in the 
stomach is a unusual situation. We report in this 
study a case of diffuse Large B cell lymphoma of the 
stomach without secondary dissemination associated 
with hepatitis C virus. The interest of this study was 
the rarity of this localization and the etiopathological 
interest because of association with hepatitis C virus. 
 
CASE REPORT 
Mrs. G.B, 76 years old, with a medical history of 
chronic stomach pain, was referred for the 
investigation of normochromic normochromic 
anemia. According to the anamnesis the symtoms 
started about three (03) months ago with a 
permanent stomach pain associated with three 
episodes of the hematemesis and melena. Context of 
fever, weight loss, night sweats was noted. She 
consulted to the general hospital of her locality where  
 
blood cell count exam discovered the anemia with 
7g/dl of hemoglobin. Then she was addressed for 
investigation in our department. The clinical 
examination found the stage I of performance status 
of WHO, with the temperature of the fever being 38° 
C. The rest of the examinations are without 
particularities. The paraclinical examination found in 
blood cell count: Leukocytes at 9800/mm3, 
Neutrophils at 1500/mm3, hemoglobin at 9g/dl, 
reticulocytes at 60000/mm3, lymphocyte at 1800 
/mm3, blood platelets at 170000 /mm3. The marrow 
bone examination was normal. We had requested a 
gastric endoscopy which noted budding gastric 
lesions of malignant appearance. Anatomopathology 
exam found a tumor proliferation consisting of 
lymphoid cells whose diameter was medium to large. 
Immunohistochemistry noted the expression of 
CD79b and it did not have a significant expression of 
CD10. These cells expressed BCL2, BCL6, MUM1.  
They didn’t express CD5 and CD3. The proliferative 
activity was variable in places. There was the presence 
of some positivity of tumor elements for C-myc gene. 
The body scan, entero-scan and the colonoscopy were 
normal. The inflammatory assessment noted CRP <6 
mg, fibrinemia 4.6 g/l, beta 2 microglobulin 3.74 mg / 
l, the LDH level was 383 IU and albumin 30 g/l with a 
gammaglobulinemia at 20 g/l. The bone marrow 
biopsy didn’t show the infiltration. The serology of 
Helicobacter pylori was negative. The serology of 
viral hepatitis C had positive with viral charge 
significant. Other viral serologies were negative (HIV, 
HVB, HTLV1). We conclude at the DLBCL located to 
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Non-Hodgkin's lymphomas are characterized by its clinical and pathological polymorphism. In the stomach, MALT lymphomas are 
common and mostly associated with Helicobacter Pylori infection. We report a case of 76-year old woman with a medical history 
of chronic stomach pain, addressed for the investigation of normochromic normocytic anemia. The clinical picture included signs 
of digestive hemorrhage and stomach pain. Gastrointestinal endoscopy and histology noted an unspecified ulcer-budding tumor 
without signs of Helibacter pylori infection. Immunohistochemistry concluded to diffuse large B cell lymphoma with CD79b +, 
BCL10 +/-, BCL2+, BCL6 +, MUM1+. The Ann Arbor classification was  stage IE. The serology of Helicobacter pylori was negative. 
Pre-treatment investigation noted a comorbity with Hepatitis C infection. This study has two interests. Firstly the rarity of the 
localization of this lymphoma, and secondly, the etiopathological interest because of association with hepatitis C virus. 
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the stomach without secondary localization (an Ann  
Arbor IE stage) associated with hepatitis C infection. 
We treated the patient with chemotherapy including 
Rituximab- Cyclophosphamide- Vincristine- 
Prednisolone associated the hepatitis viral C 
treatment and the symptoms disappeared. 
 
DISCUSSION 
Stomach is the most site of localization of extra-
ganglionic non-Hodgkin lymphoma.3,4,8 In the 
stomach, we have two forms of lymphoma: MALT 
lymphomas which is low grade lymphoma with 
indolent evolution and whose evolution can be 
towards the aggressive lymphoma. Then there is an 
aggressive form such as the Diffuse Large Cell 
Lymphoma (DLCL) that are infrequent.8,9 They are 
uncommon in children, but more common in adults 
patients10,11 concording the age of our patient. 
Etiopathologically, many advances have been made 
in understanding the mechanism of carcinogenesis of 
lymphomas. Some incriminated the infectious 
agents, other incriminated the genetic factors and 
toxic agents. The role of Helicobacter pylori has been 
described as an etiopathogenic model of gastric 
lymphomas. This bacterium is found in 80% of 
diagnosed patients.5,6 In 1991, Parsonnet et al. on a 
cohort including several thousand patients who had 
serum samples as part of a systematic review, found 
the presence of anti-Helicobacter pylori antibodies in 
90.9% of cases in patients with gastric lymphoma.12 
Several studies outside of Patersonnet et al. suggest 
the existence of a relationship between Helicobacter 
pylori and Gastric lymphoma.13,14 The mechanism by 
which this bacterium provoke a lymphomatous 
proliferation remains controversial. According to 
Delchevier JC,15 the chorion of the gastric mucosa is 
devoid of any B-lymphocytes in absence of infection 
with Helicobacter pylori. The inflammatory reaction 
induced by this bacterium causes the appearance of a 
B-lymphocyte population, then of gastric lymphoid 
nodules. The repeated antigen stimulation by this 
bacterium induces a monoclonal proliferation of B-
lymphocytes, serving as a platform for 
Lymphomatous processes.  
 
Hussel et al, in another study, have recently described 
the possible mechanism of the mode of action of 
Helicobacter. pylori.16 According to them, the 
proliferation of malignant B-lymphocyte in gastric 
lymphoma in culture would be dependent on a 
specific strain of Helicobacter pylori, the stimulation 
being in fact carried out by the activated T-
lymphocyte, specific for the Helicobacter pylori strain 
and their cytokines, and not by the bacterium itself. 
However, the direct responsibility of the bacterium in 
the genesis of Gastric Lymphoma remains to be 
proven, especially since there is a discrepancy 
between this hypothesis and the fact that more than 
half of the world population has or has had an 
infection with Helicobacter pylori without 
developing a lymphoma. Other factors could indeed 
intervene: environmental, nutritional, viral 
infections, dysregulation of immunity. 
 
In addition, the type of strain of the bacterium 
involved is certainly an element to consider that 
could partly explain the discrepancy mentioned 
above. In our study, gastrointestinal endoscopy and 
serology did not show Helicobacter Pylori. On the 
other hand, there was a viral hepatitis C virus, a virus 
that is common in low-grade of Non-Hodgkin 
Lymphoma.7,17 In this context, it would be 
understandable if the clinical findings of our patient 
was secondary to a gastric MALT lymphoma. The 
short duration of symptomatology revealed in the 
anamnesis, the endoscopic and immuhistochemical 
data excluded this possibility. Our observation could 
thus complete these last arguments that in addition 
to the Helicobacter Pylori, other factors are 
incriminated in the genesis of Gastric lymphoma. 
However by what mechanism would he obey the 
etiopathogenic model as a factor incriminating the 
hepatitis C virus? Does the chronic stimulation of the 
immune system by hepatitis C virus in particular as 
described in the study of  Besson C et al.18  serve as a 
basis for a lymphomatous stage as localized as seen in 
our study? Is it an interlinked process without there 
being a cause-and-effect phenomenon between 
gastric lymphoma and this hepatitis C virus? 
 
CONCLUSION 
The case present could add to current literature 
suggesting that apart from infection with 
Helicobacter Pylori, other factors are implicated in 
the occurrence of gastric lymphomas. It also raises 
the problem of the link between the hepatitis C virus 
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